Literature DB >> 30233867

Diagnostic benefits of the combined use of liquid-based cytology, cell block, and carcinoembryonic antigen immunocytochemistry in malignant pleural effusion.

Chang Gok Woo1, Seung-Myoung Son1, Hye-Suk Han2,3, Ki Hyeong Lee2,3, Kang-Hyeon Choe2,3, Jin Young An2,3, Ki Man Lee2,3, Young Hyun Lim3, Ho-Chang Lee1,3, Ok-Jun Lee1,3.   

Abstract

BACKGROUND: Malignant pleural effusion (MPE) is a common complication of cancer cell metastasis to the pleura. Discrimination between MPE and benign pleural effusion is necessary to design treatment strategies. Cytology is important for the diagnosis of MPE. Carcinoembryonic antigen (CEA) is an epithelial biomarker with a strong staining pattern in adenocarcinomas. Here, the diagnostic performances of liquid-based cytology (LBC), cell block (CB) preparation, and CEA immunostaining for the detection of malignancy in effusion cytology were compared in a large case series.
METHODS: In a single institution, 1,014 cytology samples from 862 patients were retrospectively collected and reviewed between January 2013 and November 2015. Ethanol-fixed, paraffin embedded CB of pleural effusions was analyzed by CEA immunostaining. Diagnostic values were compared among LBC, CB, CEA immunostaining, and the combination of two methods.
RESULTS: The sensitivity and specificity of the CB preparation were 94.3% and 98.7%, respectively, compared with 81.3% and 99.4% for LBC preparations, respectively. Combination of LBC and CB increased sensitivity by 98.3%. Although the accuracy of CEA staining itself was moderate (sensitivity, 89.8%), the combined use of CB and CEA tumor marker increased the detection rate of malignancy (sensitivity, 100%; specificity, 100%), compared with that of cytology (LBC or CB) alone.
CONCLUSIONS: The sensitivity and specificity for the diagnosis of MPE could be improved by integrating the CB and CEA staining into LBC in routine clinical practice to improve diagnostic accuracy.

Entities:  

Keywords:  Cytology; Malignant pleural effusion (MPE); carcinoembryonic antigen (CEA); cell block (CB); immunocytochemistry

Year:  2018        PMID: 30233867      PMCID: PMC6129876          DOI: 10.21037/jtd.2018.07.139

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

1.  Pleural effusion; a statistical study of 436 patients.

Authors:  E C LEUALLEN; D T CARR
Journal:  N Engl J Med       Date:  1955-01-20       Impact factor: 91.245

Review 2.  Application of immunohistochemistry to cytology.

Authors:  Larry J Fowler; Whitney A Lachar
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

3.  Comparison of diagnostic accuracy between CellprepPlus® and ThinPrep® liquid-based preparations in effusion cytology.

Authors:  Yong-Moon Lee; Ji-Yong Hwang; Seung-Myoung Son; Song-Yi Choi; Ho-Chang Lee; Eun-Joong Kim; Hye-Suk Han; Jin Young An; Joung-Ho Han; Ok-Jun Lee
Journal:  Diagn Cytopathol       Date:  2013-10-25       Impact factor: 1.582

Review 4.  Diagnostic problems in serous effusions.

Authors:  C W Bedrossian
Journal:  Diagn Cytopathol       Date:  1998-08       Impact factor: 1.582

5.  Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.

Authors:  R J Tickman; C Cohen; V A Varma; P S Fekete; P B DeRose
Journal:  Acta Cytol       Date:  1990 Jul-Aug       Impact factor: 2.319

6.  Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears.

Authors:  A Dekker; P A Bupp
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

7.  Thyroid transcription factor-1 expression in advanced non- small cell lung cancer: impact on survival outcome.

Authors:  Shereef Ahmed Elsamany; Turki M Al-Fayea; Abdullah Said Alzahrani; Waleed Nabeel Abozeed; Waseem Darwish; Mian Usman Farooq; Ahmed Salahuddin Almadani; Esraa Ahmed Bukhari
Journal:  Asian Pac J Cancer Prev       Date:  2015

8.  Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.

Authors:  Seung-Myoung Son; Hye-Suk Han; Jin Young An; Kang Hyeon Choe; Ki Man Lee; Ki Hyeong Lee; So-Seul Kim; Yong-Moon Lee; Ho-Chang Lee; Hyung Geun Song; Ok-Jun Lee
Journal:  Pathology       Date:  2015-02       Impact factor: 5.306

9.  The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions.

Authors:  J F Silverman; K Nance; B Phillips; H T Norris
Journal:  Diagn Cytopathol       Date:  1987-06       Impact factor: 1.582

10.  Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology.

Authors:  Udasimath Shivakumarswamy; Surekha U Arakeri; Mahesh H Karigowdar; Br Yelikar
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

View more
  4 in total

1.  [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].

Authors:  Ruicheng Li; Zhaowei Gao; Ke Dong; Huiping Wang; Huizhong Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

2.  Clinical Evaluation of Li Brush Endometrial Samplers for Diagnosing Endometrial Lesions in Women With Intrauterine Devices.

Authors:  Lu Han; Sijia Ma; Lanbo Zhao; Yu Liu; Yiran Wang; Xue Feng; Kailu Zhang; Lei Wang; Li Wang; Panyue Yin; Dongxin Liang; Huilian Hou; Guizhi Shi; Qiling Li
Journal:  Front Med (Lausanne)       Date:  2020-11-30

3.  Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.

Authors:  Sufei Wang; Shan Tian; Yuan Li; Na Zhan; Yingyun Guo; Yu Liu; Juanjuan Xu; Yanling Ma; Shujing Zhang; Siwei Song; Wei Geng; Hui Xia; Pei Ma; Xuan Wang; Tingting Liao; Yanran Duan; Yang Jin; Weiguo Dong
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

4.  Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients.

Authors:  Xingya Ruan; Yonghua Sun; Wei Wang; Jianwei Ye; Daoyun Zhang; Ziying Gong; Mingxia Yang
Journal:  Oncol Lett       Date:  2020-03-05       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.